AT
Healthcare & Life Sciences
AvenCell Therapeutics
United States
AvenCell Therapeutics is a Healthcare & Life Sciences startup based in the United States, most recent round Series B, 1 tracked investor.
series-b
series-b
Stage
1
Investors
About AvenCell Therapeutics
AvenCell Therapeutics is a startup based in the United States. Its most recent tracked round is Series B. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
AvenCell Therapeutics develops allogeneic cell therapies by engineering human pluripotent stem cells to treat cancer with immune cells that avoid immune rejection.
Explore AvenCell Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.